NEUROONE MEDICAL TECHNOLOGIES Corp 8-K

What Happened
NeuroOne Medical Technologies Corporation announced its financial results for the fiscal quarter ended December 31, 2025 and filed a Current Report on Form 8-K on February 17, 2026 to furnish the related press release. The press release is attached to the 8-K as Exhibit 99.1 and is incorporated by reference.

Key Details

• Item reported: 2.02 — Results of Operations and Financial Condition (press release of quarterly results).
• Filing date: February 17, 2026; quarter end: December 31, 2025.
• Exhibit furnished: 99.1 (Press Release dated February 17, 2026); Exhibit 104 (Cover Page Interactive Data File / Inline XBRL).
• The 8-K furnishes the press release rather than embedding detailed financial statements in the body of the form.

Why It Matters
This filing notifies investors that NeuroOne has released its latest quarterly earnings information; investors should review the attached press release (and any subsequent filings) to see revenue, earnings, cash flow, and management commentary. The press release may influence the company’s stock price and provides the most current operational and financial snapshot until formal quarterly filings (e.g., 10-Q) are available.